Updates on diagnosis: new tools? How can we measure activity?

Digestive and Liver Disease Supplements

Volumn 2, Issue 1, 2008, Pages 5-6

  Pallone, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 2 GLOBULIN; ALPHA1 GLYCOPROTEIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN; HEMOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; OROSOMUCOID; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL PRACTICE; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE COURSE; DNA POLYMORPHISM; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IRON BLOOD LEVEL; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 64349117609     PISSN: 15945804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1594-5804(08)60013-3     Document Type: Article

References (5)

1. Brignola C., Campieri M., Bazzocchi G., Farruggia P., Tragnone A., Lanfranchi G.A., et al. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 91 (1986) 1490-1494
2. Boirivant M., Leoni M., Tariciotti D., Fais S., Squarcia O., Pallone F., et al. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol 10 (1988) 401-405
3. Costa F., Mumolo M.G., Ceccarelli L., Bellini M., Romano M.R., Sterpi C., et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 54 (2005) 364-368
4. Feagan B., Rutgeerts P., and Schreiber S. Low baseline CRP correlates with high placebo remission rate in Crohn's disease Clinical trials at 12 weeks. Gastroenterology 128 suppl 2 (2005) A307
5. Vermeire S., van Asche G., and Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 55 (2006) 426-431